Contact UsTwo Pershing Square 2300 Main Street, Suite 170 Kansas City MO 64108
Two Pershing Square
2300 Main Street, Suite 170
Kansas City, MO 64108
Telephone: (816) 221-6600
Toll Free: 1 (877) 284-6600
Fax: (816) 221-6612
FDA Letter to Health Care Providers
Posted by the FDA on April 25, 2018.
The Issue: FDA is providing preliminary information concerning magnetic resonance (MR) thermometry reliability with magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) devices.
February 15, 2017, the FDA announced a Class I recall of the Zimmer Biomet Comprehensive Reverse Shoulder implant because these devices are fracturing at a higher rate than stated in the labeling. If this occurs, patients may need a revision surgery to remove or replace the device.
Unfortunately, in recent years, drug and product recalls have become more common. Why? What happens and how does the process work? Who is responsible for making sure these products are adequately tested before hitting the market?
Questions? Our knowledgeable staff is available at (877) 284-6600.
On September 27, 2016, the Therapeutic Goods Administration (TGA) in Australia, in consultation with Stryker Orthopaedics, issued a hazard alert for a specific range of LFIT Anatomic CoCr V40 femoral heads.
Today, the FDA issued a final order requiring manufacturers to submit a pre-market approval (PMA) application for two types of metal-on-metal hip replacement devices. These include ones with a:
The FDA announced a Class I Recall — the most serious type of recall — on yet another hip implant device. According to the FDA alert, MicroPort Orthopedics received “reports of an unexpected rate of fractures after surgery related to” its PROFEMUR Long Cobalt Chrome 8 Degree Varus/Valgus Modular Neck, Part 1254.
On June 8, 2015, the U.S. Food and Drug Administration (FDA) issued a Class I recall of the Zimmer M/L Taper with Kinective Technology Femoral Stems and Necks. The devices involved were manufactured and distributed from March 31, 2015 through April 20, 2015.